179 related articles for article (PubMed ID: 10699635)
1. Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder.
Chang S; Lee S; Lee C; Kim JI; Kim Y
Urology; 2000 Mar; 55(3):448-52. PubMed ID: 10699635
[TBL] [Abstract][Full Text] [Related]
2. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
Zhou JT; Cai ZM; Li NC; Na YQ
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
[TBL] [Abstract][Full Text] [Related]
3. Biological characteristics of inverted papilloma of the urinary bladder.
Urakami S; Igawa M; Shirakawa H; Shiina H; Ishibe T
Br J Urol; 1996 Jan; 77(1):55-60. PubMed ID: 8653317
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of clusterin in transitional cell carcinoma of the bladder is related to disease progression and recurrence.
Miyake H; Gleave M; Kamidono S; Hara I
Urology; 2002 Jan; 59(1):150-4. PubMed ID: 11796313
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
6. Glutathione S-transferase activity and subunit composition in transitional cell cancer and mucosa of the human bladder.
Berendsen CL; Peters WH; Scheffer PG; Bouman AA; Boven E; Newling DW
Urology; 1997 Apr; 49(4):644-51. PubMed ID: 9111645
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin tissue expression and urinary soluble forms of E-cadherin in patients with bladder transitional cell carcinoma.
Shi B; Laudon V; Yu S; Dong D; Zhu Y; Xu Z
Urol Int; 2008; 81(3):320-4. PubMed ID: 18931551
[TBL] [Abstract][Full Text] [Related]
8. Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder.
Lazzeri M; Vannucchi MG; Spinelli M; Bizzoco E; Beneforti P; Turini D; Faussone-Pellegrini MS
Eur Urol; 2005 Oct; 48(4):691-8. PubMed ID: 15992990
[TBL] [Abstract][Full Text] [Related]
9. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
11. Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder.
Elsamman E; Fukumori T; Kasai T; Nakatsuji H; Nishitani MA; Toida K; Ali N; Kanayama HO
BJU Int; 2006 Jun; 97(6):1202-7. PubMed ID: 16686711
[TBL] [Abstract][Full Text] [Related]
12. Glucose transporter-1 expression in urothelial papilloma of the bladder.
Lee JH; Kim YW; Chang SG
Urol Int; 2005; 74(3):268-71. PubMed ID: 15812216
[TBL] [Abstract][Full Text] [Related]
13. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemistry of collagenase expression in transitional cell carcinoma of the bladder.
Hattori M; Ohno E; Kuramoto H
Acta Cytol; 2000; 44(5):771-7. PubMed ID: 11015978
[TBL] [Abstract][Full Text] [Related]
15. Expression of beta-human chorionic gonadotropin (beta-hCG) in non-trophoblastic elements of transitional cell carcinoma of the bladder: possible relationship with the prognosis.
Bacchi CE; Coelho KI; Goldberg J
Rev Paul Med; 1993; 111(3):412-6. PubMed ID: 8108635
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.
Nakopoulou L; Constantinides C; Papandropoulos J; Theodoropoulos G; Tzonou A; Giannopoulos A; Zervas A; Dimopoulos C
Urology; 1995 Sep; 46(3):334-40. PubMed ID: 7660508
[TBL] [Abstract][Full Text] [Related]
17. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
[TBL] [Abstract][Full Text] [Related]
18. [Dependence of keratin No. 17 distribution on the degree of malignancy of bladder tumors].
Gel'shteĭn VI; Chipysheva TA; Ermilova VD; Troianovskiĭ SM
Arkh Patol; 1992; 54(2):21-5. PubMed ID: 1381915
[TBL] [Abstract][Full Text] [Related]
19. Alterations in polymeric immunoglobulin receptor expression and secretory component levels in bladder carcinoma.
Rossel M; Billerey C; Bittard H; Ksiazek P; Alber D; Revillard JP; Vuitton DA
Urol Res; 1991; 19(6):361-6. PubMed ID: 1759330
[TBL] [Abstract][Full Text] [Related]
20. [Incidental inverted papilloma during the clinical follow-up of superficial transitional cell carcinoma in the urinary bladder].
Sasamoto H; Matsumoto K; Matsushita K; Tsuboi T; Yamashita H; Satoh T; Iwamura M; Baba S; Mikami T
Hinyokika Kiyo; 2008 Feb; 54(2):131-4. PubMed ID: 18323173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
